Did you spit in a tube for 23andMe? If so, your genetic data may soon be handed over to a new company — Regeneron. Just four years ago, when 23andMe went public, the company was valued at $6 billion.

New York and other states filed a lawsuit seeking to block 23andMe, the bankrupt genetic testing firm, from selling millions of Americans' genetic data to the highest bidder. A total of 28 state ...

A bankruptcy judge has approved the sale of the insolvent genetics firm 23andMe to a nonprofit run by one of the company's co-founders. The deal effectively avoids the controversial transfer of DNA ...

Editor’s Note: An earlier version of this piece failed to specify that the 23andMe sale is ongoing and is still subject to court approval. We have corrected this ...

Home DNA kits aren't just for fun. They can affect your whole financial future.

23andMe, a popular direct-to-consumer genetic testing company, made headlines after its CEO pledged to help reunite the more than 2,300 children separated from their parents at the U.S.’s southern ...

23andMe was once a high-flying biotech firm. It collected a trove of DNA data on millions of its customers, and then it went bust. The fate of that data has been at the center of a legal battle over ...

23andMe, which provides DNA testing kits for consumers, is telling outside app developers that they'll no longer have access to the company's raw genomic data. Developers of health apps, weight loss ...

23andMe, the DNA testing company once valued at $6 billion, filed for bankruptcy Monday, while its founder and CEO Anne Wojcicki resigned her position. More than 15 million people submitted DNA ...

The DNA data of millions of people who used 23andMe's services won't be sold to a pharmaceutical company. A bankruptcy judge greenlighted the sale... A bankruptcy judge has approved the sale of the ...